Inhibition of MCP-1/CCR2 Signaling Pathway is Important for Reduction of Ischemic Brain Damage With AT1 Receptor Blockade

被引：0
|
作者：
Tsukuda, Kana [1 ]
Mogi, Masaki [1 ]
Iwanami, Jun [1 ]
Min, Li-Juan [1 ]
Jing, Fei [1 ]
Oshima, Kousei [1 ]
Horiuchi, Masatsugu [1 ]
机构：
[1] Ehime Univ, Tohon, Ehime, Japan
来源：
HYPERTENSION | 2011年 / 58卷 / 05期
关键词：
Angiotensin II Stroke Inflammation;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E179 / E179
页数：1
相关论文
共 50 条
  • [1] Irbesartan attenuates ischemic brain damage by inhibition of MCP-1/CCR2 signaling pathway beyond AT1 receptor blockade
    Tsukuda, Kana
    Mogi, Masaki
    Iwanami, Jun
    Min, Li-Juan
    Jing, Fei
    Oshima, Kousei
    Horiuchi, Masatsugu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 409 (02) : 275 - 279
  • [2] Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy
    Kanamori, Hiroshi
    Matsubara, Takeshi
    Mima, Akira
    Sumi, Eriko
    Nagai, Kojiro
    Takahashi, Toshikazu
    Abe, Hideharu
    Iehara, Noriyuki
    Fukatsu, Atsushi
    Okamoto, Hiroshi
    Kita, Toru
    Doi, Toshio
    Arai, Hidenori
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 360 (04) : 772 - 777
  • [3] The CCR2/MCP-1 Chemokine Pathway and Lung Adenocarcinoma
    Mittal, Payal
    Wang, Liqing
    Akimova, Tatiana
    Leach, Craig A.
    Clemente, Jose C.
    Sender, Matthew R.
    Chen, Yao
    Turunen, Brandon J.
    Hancock, Wayne W.
    CANCERS, 2020, 12 (12) : 1 - 19
  • [4] Inhibition of MCP-1/CCR2 signaling pathway is involved in synergistic inhibitory effects of irbesartan with rosuvastatin on vascular remodeling
    Ohshima, Kousei
    Mogi, Masaki
    Nakaoka, Hirotomo
    Jing, Fei
    Iwanami, Jun
    Min, Li-Juan
    Tsukuda, Kana
    Kanno, Harumi
    Ogimoto, Akiyoshi
    Higaki, Jitsuo
    Horiuchi, Masatsugu
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2012, 6 (06) : 375 - 384
  • [5] THE ROLE OF MCP-1/CCR2 IN ETHANOL NEUROTOXICITY IN THE DEVELOPING BRAIN
    Zhang, K.
    Wang, H.
    Xu, M.
    Frank, J. A.
    Luo, J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2017, 41 : 46A - 46A
  • [6] Role of MCP-1/CCR2 signaling in progressive renal fibrosis.
    Kitagawa, K
    Wada, T
    Furuichi, K
    Iwata, Y
    Mukaida, N
    Mastushima, K
    Yokoyama, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 593A - 593A
  • [7] Role of MCP-1/CCR2 in diabetic glomerulosclerosis
    Kanamori, Hiroshi
    Matsubara, Takeshi
    Mima, Akira
    Sumi, Eriko
    Iehara, Noriyuki
    Fukatsu, Atsushi
    Doi, Toshio
    Kita, Toru
    Arai, Hidenori
    DIABETES, 2006, 55 : A180 - A180
  • [8] Role of MCP-1 and CCR2 in alcohol neurotoxicity
    Zhang, Kai
    Luo, Jia
    PHARMACOLOGICAL RESEARCH, 2019, 139 : 360 - 366
  • [9] Role of MCP-1/CCR2 signaling in progressive renal fibrosis.
    Kitagawa, K
    Wada, T
    Furuichi, K
    Iwata, Y
    Kuziel, WA
    Mukaida, N
    Matsushima, K
    Kobayashi, K
    Yokoyama, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 355A - 355A
  • [10] MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression
    Pozzi, Sabina
    Scomparin, Anna
    Ben-Shushan, Dikla
    Yeini, Eilam
    Ofek, Paula
    Nahmad, Alessio D.
    Soffer, Shelly
    Ionescu, Ariel
    Ruggiero, Antonella
    Barzel, Adi
    Brem, Henry
    Hyde, Thomas M.
    Barshack, Iris
    Sinha, Sanju
    Ruppin, Eytan
    Weiss, Tomer
    Madi, Asaf
    Perlson, Eran
    Slutsky, Inna
    Florindo, Helena F.
    Satchi-Fainaro, Ronit
    JCI INSIGHT, 2022, 7 (17)
12345